Startup EPM launches, high off cannabinoid acid innovation
When Sue Sisley opened the first bag of her Washington-licensed weed, she knew something was wrong. It came with the verisimilitude of government cheese, a bureaucratic knock-off that neither looked nor smelled like the real thing.
“It was this green powder with little sticks and leaves,” Sisley, head of the Scottsdale Research Group, told Endpoints News earlier this month.”So diluted.”
Two years ago, Sisley gained approval for a PhII study on the effects of marijuana on veterans with PTSD. Since the 1960s, though, the DEA has only allowed one lab in the country, at the University of Mississippi, to grow marijuana. That meant that when Sisley and other researchers began some of the first modern studies on medical marijuana, they were forced to use a product that looks more like oregano than weed. Also, it appeared to be moldy.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.